These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14574053)

  • 21. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).
    Howlett JG; Ezekowitz JA; Podder M; Hernandez AF; Diaz R; Dickstein K; Dunlap ME; Corbalán R; Armstrong PW; Starling RC; O'Connor CM; Califf RM; Fonarow GC;
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):534-42. PubMed ID: 23899930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.
    Peacock WF; Fonarow GC; Emerman CL; Mills RM; Wynne J; ;
    Cardiology; 2007; 107(1):44-51. PubMed ID: 16741357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.
    Lewis DA; Gurram NR; Abraham WT; Akers WS
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S16-20. PubMed ID: 12966902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of nesiritide in the management of acute decompensated heart failure.
    Kayser SR
    Prog Cardiovasc Nurs; 2002; 17(2):89-95. PubMed ID: 11986542
    [No Abstract]   [Full Text] [Related]  

  • 25. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.
    Reed SD; Kaul P; Li Y; Eapen ZJ; Davidson-Ray L; Schulman KA; Massie BM; Armstrong PW; Starling RC; O'Connor CM; Hernandez AF; Califf RM
    J Card Fail; 2013 Sep; 19(9):611-20. PubMed ID: 24054337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
    Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
    JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide: spectrum of application. Nesiritide (recombinant BNP) for heart failure.
    Fonarow GC
    Heart Fail Rev; 2003 Oct; 8(4):321-5. PubMed ID: 14574051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term mortality risk in emergency department acute heart failure.
    Peacock WF; Nowak R; Christenson R; DiSomma S; Neath SX; Hartmann O; Mueller C; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Filippatos GS; Anand I; Ng LL; Daniels LB; Morgenthaler N; Anker SD; Maisel AS
    Acad Emerg Med; 2011 Sep; 18(9):947-58. PubMed ID: 21906204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency department management of patients with acute decompensated heart failure.
    Peacock WF; Emerman CL
    Heart Fail Rev; 2004 Jul; 9(3):187-93. PubMed ID: 15809816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nesiritide fails to reduce the mortality of patients with acute decompensated heart failure: an updated systematic review and cumulative meta-analysis.
    Yan B; Peng L; Zhao X; Chung H; Li L; Zeng L; Ong H; Wang G
    Int J Cardiol; 2014 Dec; 177(2):505-9. PubMed ID: 25183537
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of nesiritide on length of hospital stay in patients with decompensated heart failure.
    Chang R; Elatre WA; Heywood JT
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):173-7. PubMed ID: 15378137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.
    Kaul P; Reed SD; Hernandez AF; Howlett JG; Ezekowitz JA; Li Y; Zheng Y; Rouleau JL; Starling RC; O'Connor CM; Califf RM; Armstrong PW
    JACC Heart Fail; 2013 Dec; 1(6):523-30. PubMed ID: 24622005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital policies for treatment of acute decompensated heart failure.
    Vats V; DiDomenico RJ; Wojtynek JE; Theobald JC; Schumock GT
    Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting.
    Lam LL; Cameron PA; Schneider HG; Abramson MJ; Müller C; Krum H
    Ann Intern Med; 2010 Dec; 153(11):728-35. PubMed ID: 21135296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department visits for heart failure and subsequent hospitalization or observation unit admission.
    Blecker S; Ladapo JA; Doran KM; Goldfeld KS; Katz S
    Am Heart J; 2014 Dec; 168(6):901-8.e1. PubMed ID: 25458654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain natriuretic peptide (nesiritide) in the treatment of heart failure.
    Bettencourt P
    Cardiovasc Drug Rev; 2002; 20(1):27-36. PubMed ID: 12070532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.
    Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL
    JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.